Morgan Stanley’s Rallybio RLYB Stock Holding History
Bought
Maintained
Sold
Other funds holding RLYB
ACM
TGA
PBPIA
NCM
AC
Morgan Stanley's RLYB Position: Q2 2026 in Review
Morgan Stanley reduced its Rallybio (RLYB) stake by 0.79% in Q2 2026, selling an estimated $13 and leaving 125 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #7407.
Morgan Stanley first reported a position in RLYB in Q3 2021 and has held it in 20 quarters since. The position peaked at $237K in Q4 2023. 37 funds tracked by Wall St. Rank hold RLYB as of Q2 2026.
- Morgan Stanley held 125 shares of Rallybio worth $2K as of Q2 2026.
- Morgan Stanley sold 1 Rallybio share in Q2 2026, an estimated $13.
- Rallybio made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #7407 holding.
- Morgan Stanley first reported a position in Rallybio in Q3 2021 and has held it in 20 quarters since.
- Morgan Stanley's Rallybio position peaked at $237K in Q4 2023.
- 37 funds tracked by Wall St. Rank held Rallybio as of Q2 2026.
Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.